Patent assignee · CH · COMPANY

ObsEva S.A.

11Patents
11Active
11Granted
47Portfolio score

Filing activity: Sep 8, 2014 → Mar 26, 2020

Most-cited patents

PatentTitleAreaCited byStatus
US9670155B2 Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists Chemistry; Metallurgy 7 Active
US9962367B2 Oral formulations of pyrrolidine derivatives Human Necessities 4 Active
US10047048B2 Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists Chemistry; Metallurgy 3 Active
US9718772B2 Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same Chemistry; Metallurgy 2 Active
US10478420B2 Oral formulations of pyrrolidine derivatives Human Necessities 2 Active
US10555934B2 Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof Human Necessities 2 Active
US10604482B2 Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists Chemistry; Metallurgy 2 Active
US11312683B2 Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists Chemistry; Metallurgy 0 Active
US10752583B2 Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same Chemistry; Metallurgy 0 Active
US11419851B2 Oral formulations of pyrrolidine derivatives Human Necessities 0 Active
US11524003B2 Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.